Novartis

Novartis funnels $300M into early biologic drug manufacturing
BioPharma Dive
Mon, 09/12/22 - 11:36 pm
Novartis
biologics
drug manufacturing
Slovenia
Austria
ESMO 2022 – the new liver cancer entrants line up
EP Vantage
Thu, 09/8/22 - 10:39 am
ESMO
liver cancer
Keytruda
tislelizumab
camrelizumab
Merck
BeiGene
Novartis
Novartis' Entresto infringes on university patents, lawsuit claims
Endpoints
Wed, 08/31/22 - 10:29 am
Novartis
Entresto
legal
patents
Backed by Medicxi, Novartis vets launch rare blood disorder biotech with fresh take on drug class used in cancers
Endpoints
Sun, 08/28/22 - 10:10 pm
Novartis
AKT inhibitors
Vaderis Therapeutics
Medicxi
Novartis cuts manufacturing jobs, closes North Carolina plant ahead of Sandoz spinoff
Fierce Pharma
Fri, 08/26/22 - 10:45 am
Novartis
drug manufacturing
Sandoz
generics
Revealed: which pharma companies leading the way in artificial intelligence
Clinical Trials Arena
Fri, 08/26/22 - 10:37 am
artificial intelligence
Pfizer
Novartis
AstraZeneca
Johnson & Johnson
Bristol Myers Squibb
Takeda
GSK
Bayer
Astellas
It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery
Fierce Pharma
Thu, 08/25/22 - 11:30 am
spinoffs
Novartis
Sandoz
generics
Safety worries spur Novartis to suspend drug dosing in Huntington’s trial
BioPharma Dive
Thu, 08/25/22 - 11:29 am
Novartis
Huntington's disease
clinical trials
branaplam
Merck backs radiopharmaceutical startup Aktis, joining other high-profile backers
BioPharma Dive
Thu, 08/25/22 - 10:55 am
Aktis Oncology
radiopharmaceuticals
Merck
Novartis
Bristol Myers Squibb
Third Harmonic, with an old Novartis drug in hand, braves frosty IPO waters in a quick-fire cash grab
Fierce Biotech
Wed, 08/24/22 - 10:40 pm
Third Harmonic Bio
IPOs
Novartis
allergies
inflammatory diseases
Vaderis Forms to Tackle Vascular Malformations with Novartis Vet at the Helm
BioSpace
Mon, 08/22/22 - 10:24 am
Vaderis
Novartis
vascular malformations
clinical trials
VAD044
Novartis' MS drug Gilenya could inspire new chronic kidney disease treatment
Fierce Biotech
Fri, 08/19/22 - 10:47 am
Novartis
Gilenya
kidney disease
chronic kidney disease
Novartis' former weight loss med Sanorex at center of New Jersey pharma chief's guilty plea
Fierce Pharma
Tue, 08/16/22 - 10:56 am
Novartis
Sanorex
weight loss
legal
Alain Bouaziz
Novartis bid to repurpose rare disease drug for cancer falls short in third trial
BioPharma Dive
Mon, 08/15/22 - 10:15 am
Novartis
cancer
clinical trials
lung cancer
canakinumab
Novartis reports deaths of two patients treated with Zolgensma gene therapy
BioPharma Dive
Thu, 08/11/22 - 11:32 pm
Novartis
gene therapy
Zolgensma
SMA
patient deaths
spinal muscular atrophy
FDA converts Novartis' NSCLC drug to a full approval with confirmatory data
Endpoints
Thu, 08/11/22 - 11:22 pm
Novartis
Tabrecta
solid tumors
FDA
non-small cell lung cancer
Novartis tips Lucentis to weather the arrival of biosimilar copies in Europe
Biopharma Reporter
Thu, 08/11/22 - 12:30 pm
Novartis
Lucentis
biosimilars
patents
Europe
BeiGene and Novartis Make Late-Stage Progress against Liver Cancer
BioSpace
Tue, 08/9/22 - 12:14 pm
Novartis
BeiGene
hepatocellular carcinoma
liver cancer
clinical trials
Novartis, UC Berkeley-spawned startup snags $65M to keep key proteins out of the cell’s trash can
MedCity News
Tue, 08/2/22 - 12:06 am
Vicinitas Therapeutics
small molecule drugs
UC Berkley
Novartis
Drugmakers leap back into fading heart drug market
Beckers Hospital Review
Thu, 07/28/22 - 06:40 pm
Bristol Myers Squibb
Novartis
Merck
Alnylam Pharmaceuticals
Amgen
hypertension
cholesterol

Pages